| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1359-1366, Copyright © 1994 by Endocrine Society
ARTICLES |
T Ikonen, JJ Palvimo, PJ Kallio, P Reinikainen and OA Janne
Department of Physiology, University of Helsinki, Finland.
The effect of modulators of protein phosphorylation on the transcriptional activity of the androgen receptor (AR) was studied under transient expression conditions. Activators of protein kinase-A [8-bromo-cAMP (8-Br-cAMP)] and protein kinase-C (phorbol 12-myristate 13-acetate) or an inhibitor of protein phosphatase-1 and -2A (okadaic acid) influenced minimally pMMTV-chloramphenicol acetyl-transferase (CAT) activity in CV-1 cells cotransfected with an AR expression plasmid in the absence of androgen. In the presence of testosterone, however, all compounds enhanced AR-mediated transactivation by 2- to 4- fold. A nonsteroidal antiandrogen, Casodex, behaved as a pure antagonist; it blunted the action of testosterone and was not rendered agonistic by activators of protein kinase-A. A reporter plasmid containing two androgen response elements (AREs) in front of the thymidine kinase promoter (pARE2tk-CAT) was also used to examine promoter specificity. It was activated by 8-Br-cAMP, forskolin, or okadaic acid even without AR or androgen. However, when forskolin or okadaic acid was used together with androgen and AR, the resulting AR- dependent transactivation of pARE2tk-CAT was more than additive. Intact DNA- and ligand-binding domains, but not the N-terminal amino acid residues 40-147, of the receptor were mandatory for the synergism between protein kinase-A activators and androgen. Immunoreactive AR content in transfected COS-1 cells was not influenced by exposure to 8- Br-cAMP. Similar results were obtained by ligand binding assays. Quantitative or qualitative differences were not observed in DNA- binding characteristics between receptors extracted from cells treated with testosterone with or without protein kinase-A activator. Collectively, the synergistic stimulation of AR-dependent transactivation by androgen and protein kinase activators is not due to changes in cellular AR content or affinity of the receptor for the cognate DNA element; rather, this phenomenon seems to result from altered interaction of ligand-activated AR with other proteins in the transcription machinery.
This article has been cited by other articles:
![]() |
B. Tan, X. Long, H. Nakshatri, K. P Nephew, and R. M Bigsby Striatin-3{gamma} inhibits estrogen receptor activity by recruiting a protein phosphatase J. Mol. Endocrinol., May 1, 2008; 40(5): 199 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, K. C. Ahn, N. A. Gee, M. I. Ahmed, A. J. Duleba, L. Zhao, S. J. Gee, B. D. Hammock, and B. L. Lasley Triclocarban Enhances Testosterone Action: A New Type of Endocrine Disruptor? Endocrinology, March 1, 2008; 149(3): 1173 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-H. Ma, L. Xia, S. J. Desai, D. L. Boucher, Y. Guan, H.-M. Shih, X.-B. Shi, R. W. deVere White, H.-W. Chen, C. G. Tepper, et al. Male Germ Cell-Associated Kinase, a Male-Specific Kinase Regulated by Androgen, Is a Coactivator of Androgen Receptor in Prostate Cancer Cells. Cancer Res., September 1, 2006; 66(17): 8439 - 8447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gioeli, B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization Mol. Endocrinol., March 1, 2006; 20(3): 503 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Gregory, Y. E. Whang, W. McCall, X. Fei, Y. Liu, L. A. Ponguta, F. S. French, E. M. Wilson, and H. S. Earp III Heregulin-Induced Activation of HER2 and HER3 Increases Androgen Receptor Transactivation and CWR-R1 Human Recurrent Prostate Cancer Cell Growth Clin. Cancer Res., March 1, 2005; 11(5): 1704 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahman, H. Miyamoto, and C. Chang Androgen Receptor Coregulators in Prostate Cancer: Mechanisms and Clinical Implications Clin. Cancer Res., April 1, 2004; 10(7): 2208 - 2219. [Full Text] [PDF] |
||||
![]() |
Y. Zagar, G. Chaumaz, and M. Lieberherr Signaling Cross-talk from G{beta}4 Subunit to Elk-1 in the Rapid Action of Androgens J. Biol. Chem., January 23, 2004; 279(4): 2403 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Rigas, D. M. Ozanne, D. E. Neal, and C. N. Robson The Scaffolding Protein RACK1 Interacts with Androgen Receptor and Promotes Cross-talk through a Protein Kinase C Signaling Pathway J. Biol. Chem., November 14, 2003; 278(46): 46087 - 46093. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Bakin, D. Gioeli, R. A. Sikes, E. A. Bissonette, and M. J. Weber Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells Cancer Res., April 15, 2003; 63(8): 1981 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Heinlein and C. Chang The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions Mol. Endocrinol., October 1, 2002; 16(10): 2181 - 2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gioeli, S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, et al. Androgen Receptor Phosphorylation. REGULATION AND IDENTIFICATION OF THE PHOSPHORYLATION SITES J. Biol. Chem., August 2, 2002; 277(32): 29304 - 29314. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueda, N. Bruchovsky, and M. D. Sadar Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways J. Biol. Chem., February 22, 2002; 277(9): 7076 - 7085. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kim, C. W. Gregory, F. S. French, G. J. Smith, and J. L. Mohler Androgen Receptor Expression and Cellular Proliferation During Transition from Androgen-Dependent to Recurrent Growth after Castration in the CWR22 Prostate Cancer Xenograft Am. J. Pathol., January 1, 2002; 160(1): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-F. Lee, J. Guan, Y. Qiu, and H.-J. Kung Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion Kinase Mol. Cell. Biol., December 15, 2001; 21(24): 8385 - 8397. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koutsilieris, C. Mitsiades, T. Dimopoulos, A. Ioannidis, A. Ntounis, and T. Lambou A Combination Therapy of Dexamethasone and Somatostatin Analog Reintroduces Objective Clinical Responses to LHRH Analog in Androgen Ablation-Refractory Prostate Cancer Patients J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5729 - 5736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Grossmann, H. Huang, and D. J. Tindall Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1687 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Chung, S. H. Mitchell, J.-S. Zhang, and C. Y. F. Young Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells Carcinogenesis, August 1, 2001; 22(8): 1201 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lin, S. Yeh, H.-Y. Kang, and C. Chang Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor PNAS, June 7, 2001; (2001) 121173298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thompson, F. Saatcioglu, O. A. Janne, and J. J. Palvimo Disrupted Amino- and Carboxyl-Terminal Interactions of the Androgen Receptor Are Linked to Androgen Insensitivity Mol. Endocrinol., June 1, 2001; 15(6): 923 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Gregory, R. T. Johnson Jr., J. L. Mohler, F. S. French, and E. M. Wilson Androgen Receptor Stabilization in Recurrent Prostate Cancer Is Associated with Hypersensitivity to Low Androgen Cancer Res., April 1, 2001; 61(7): 2892 - 2898. [Abstract] [Full Text] |
||||
![]() |
B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein Mol. Cell. Biol., December 1, 2000; 20(23): 8720 - 8730. [Abstract] [Full Text] |
||||
![]() |
M. D. Sadar and M. E. Gleave Ligand-independent Activation of the Androgen Receptor by the Differentiation Agent Butyrate in Human Prostate Cancer Cells Cancer Res., October 1, 2000; 60(20): 5825 - 5831. [Abstract] [Full Text] |
||||
![]() |
H Poukka, U Karvonen, N Yoshikawa, H Tanaka, J. Palvimo, and O. Janne The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor J. Cell Sci., January 9, 2000; 113(17): 2991 - 3001. [Abstract] [PDF] |
||||
![]() |
H. Poukka, P. Aarnisalo, H. Santti, O. A. Janne, and J. J. Palvimo Coregulator Small Nuclear RING Finger Protein (SNURF) Enhances Sp1- and Steroid Receptor-mediated Transcription by Different Mechanisms J. Biol. Chem., January 7, 2000; 275(1): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Poukka, P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription J. Biol. Chem., July 2, 1999; 274(27): 19441 - 19446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Abreu-Martin, A. Chari, A. A. Palladino, N. A. Craft, and C. L. Sawyers Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer Mol. Cell. Biol., July 1, 1999; 19(7): 5143 - 5154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yeh, H.-K. Lin, H.-Y. Kang, T. H. Thin, M.-F. Lin, and C. Chang From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells PNAS, May 11, 1999; 96(10): 5458 - 5463. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Stubbs, P. D. Abel, M. Golding, G. Bhangal, Q. Wang, J. Waxman, G. W.H. Stamp, and E.-N. Lalani Differentially Expressed Genes in Hormone Refractory Prostate Cancer : Association with Chromosomal Regions Involved with Genetic Aberrations Am. J. Pathol., May 1, 1999; 154(5): 1335 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hansen Ree, V. Hansson, S. I. Walaas, W. Eskild, and K. Austlid Taskén Calcium/Phospholipid-Dependent Protein Kinases in Rat Sertoli Cells: Regulation of Androgen Receptor Messenger Ribonucleic Acid Biol Reprod, May 1, 1999; 60(5): 1257 - 1262. [Abstract] [Full Text] |
||||
![]() |
M. D. Sadar Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways J. Biol. Chem., March 19, 1999; 274(12): 7777 - 7783. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text] |
||||
![]() |
A.-M. Moilanen, H. Poukka, U. Karvonen, M. Häkli, O. A. Jänne, and J. J. Palvimo Identification of a Novel RING Finger Protein as a Coregulator in Steroid Receptor-Mediated Gene Transcription Mol. Cell. Biol., September 1, 1998; 18(9): 5128 - 5139. [Abstract] [Full Text] |
||||
![]() |
A.-M. Moilanen, U. Karvonen, H. Poukka, O. A. Jänne, and J. J. Palvimo Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase Mol. Biol. Cell, September 1, 1998; 9(9): 2527 - 2543. [Abstract] [Full Text] |
||||
![]() |
M. J. Gerdes, T. D. Dang, M. Larsen, and D. R. Rowley Transforming Growth Factor-{beta}1 Induces Nuclear to Cytoplasmic Distribution of Androgen Receptor and Inhibits Androgen Response in Prostate Smooth Muscle Cells Endocrinology, August 1, 1998; 139(8): 3569 - 3577. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aarnisalo, J. J. Palvimo, and O. A. Janne CREB-binding protein in androgen receptor-mediated signaling PNAS, March 3, 1998; 95(5): 2122 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. H. Ding, D. E. Moller, W. P. Feeney, V. Didolkar, A. M. Nakhla, L. Rhodes, W. Rosner, and R. G. Smith Sex Hormone-Binding Globulin Mediates Prostate Androgen Receptor Action via a Novel Signaling Pathway Endocrinology, January 1, 1998; 139(1): 213 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ikonen, J. J. Palvimo, and O. A. Janne Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators J. Biol. Chem., November 21, 1997; 272(47): 29821 - 29828. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Karvonen, P. J. Kallio, O. A. Janne, and J. J. Palvimo Interaction of Androgen Receptors with Androgen Response Element in Intact Cells. ROLES OF AMINO- AND CARBOXYL-TERMINAL REGIONS AND THE LIGAND J. Biol. Chem., June 20, 1997; 272(25): 15973 - 15979. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Nakhla, N. A. Romas, and W. Rosner Estradiol Activates the Prostate Androgen Receptor and Prostate-specific Antigen Secretion through the Intermediacy of Sex Hormone-binding Globulin J. Biol. Chem., March 14, 1997; 272(11): 6838 - 6841. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Yen, Y. Liu, J. J. Palvimo, M. Trifiro, J. Whang, L. Pinsky, O. A. Jänne, and W. W. Chin Mutant and Wild-Type Androgen Receptors Exhibit Cross-Talk on Androgen-, Glucocorticoid-, and Progesterone-Mediated Transcription Mol. Endocrinol., February 1, 1997; 11(2): 162 - 171. [Abstract] [Full Text] |
||||
![]() |
J. J. Palvimo, P. Reinikainen, T. Ikonen, P. J. Kallio, A. Moilanen, and O. A. Janne Mutual Transcriptional Interference between RelA and Androgen Receptor J. Biol. Chem., September 27, 1996; 271(39): 24151 - 24156. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Nazareth and N. L. Weigel Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway J. Biol. Chem., August 16, 1996; 271(33): 19900 - 19907. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yeung, X. Li, J. Ellett, J. Trapman, C. Kao, and L. W. K. Chung Regions of Prostate-specific Antigen (PSA) Promoter Confer Androgen-independent Expression of PSA in Prostate Cancer Cells J. Biol. Chem., December 22, 2000; 275(52): 40846 - 40855. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lin, S. Yeh, H.-Y. Kang, and C. Chang Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor PNAS, June 19, 2001; 98(13): 7200 - 7205. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |